Australia markets closed

Invitae Corporation (0JDB.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.0005-0.0013 (-72.22%)
As of 02:50PM BST. Market open.
Full screen
Previous close0.0018
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0000 - 0.0000
52-week range
Volume11,700
Avg. volume225,013
Market cap456
Beta (5Y monthly)1.52
PE ratio (TTM)N/A
EPS (TTM)-2.0560
Earnings date30 May 2024 - 04 June 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    Labcorp Announces Winning Bid for Select Assets of Invitae

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company. Before the transaction can proceed, the court overseeing the process must issue an approval order following a hearing currently scheduled for May 6, 2024.

  • PR Newswire

    Invitae Publishes its Environmental, Social and Governance (ESG) Report

    Invitae (OTC: NVTA), a leading medical genetics company, today published its 2024 Environmental, Social and Governance (ESG) Report. This report provides a holistic view of the company's approach to ESG and its performance and progress through measurable data and metrics during the 2023 fiscal year.

  • PR Newswire

    Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process

    Invitae (OTC: NVTA), a leading medical genetics company, announced today that it is building on previous actions to manage costs and improve its business structure by filing for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of New Jersey. Through this filing, the Company intends to safeguard its business, customers, patients and employees while working to execute an efficient and value-maximizing sale process with the support of its senior noteholders.